
{
    "credit": [
        {
            "email": "krzysimon@gmail.com",
            "name": "Krzysztof Adam Simon",
            "typeEntity": "Person",
            "typeRoles": [
            ]
        }
    ],
    "labels": {
        "topic": [
            {
                "term": "Drug metabolism",
                "uri": "http://edamontology.org/topic_3375"
            },
            {
                "term": "Virology",
                "uri": "http://edamontology.org/topic_0781"
            },
            {
                "term": "Pharmacology",
                "uri": "http://edamontology.org/topic_0202"
            },
            {
                "term": "Surgery",
                "uri": "http://edamontology.org/topic_3421"
            },
            {
                "term": "Preclinical and clinical studies",
                "uri": "http://edamontology.org/topic_3379"
            }
        ]
    },
    "publication": [
        {
            "doi": "10.5114/CEH.2019.87634",
            "pmcid": "PMC6781817",
            "pmid": "31598558"
        }
    ],
    "summary": {
        "biotoolsCURIE": "biotools:hep-druginteractions",
        "biotoolsID": "hep-druginteractions",
        "description": "Effect of comedication on ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin therapy in chronic hepatitis C.\n\nCookies help us deliver our services. By using our services, you agree to our use of cookies. OK Learn more.\n\nAccess our free, comprehensive and user-friendly drug interaction charts.\n\n||| CORRECT NAME OF TOOL COULD ALSO BE 'OBV', 'OBV PTV', 'PTV', 'RBV'",
        "homepage": "http://www.hep-druginteractions.org/",
        "name": "hep-druginteractions"
    }
}